Con: Contrast-induced nephropathy-should we try to avoid contrast media in patients with chronic kidney disease?

13Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The incidence of acute kidney injury (AKI) attributed to iodinated contrast has been over-estimated and this has led clinicians to withhold potentially life-saving diagnostic and therapeutic interventions. There is mounting evidence that iodinated contrast plays only a minor role in the development of AKI in comparison with more significant risk factors such as preexisting renal dysfunction, hemodynamic instability and exposure to nephrotoxic drugs. We will present data which challenge the dogma of avoiding iodinated contrast in patients with reduced renal function. Based on a rational and individualized risk-benefit analysis, we believe it is preferable to utilize iodinated contrast if alternate diagnostic or therapeutic options are comparatively ineffective or hazardous.

Cite

CITATION STYLE

APA

Ewing, M. J., & Eidt, J. F. (2018). Con: Contrast-induced nephropathy-should we try to avoid contrast media in patients with chronic kidney disease? Nephrology Dialysis Transplantation, 33(8), 1320–1322. https://doi.org/10.1093/ndt/gfy153

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free